β-Adrenoceptors differentially regulate vascular tone and angiogenesis of rat aorta via ERK1/2 and p38

Perez-Aso, M., Flacco, N., Carpena, N. , Montesinos, M. C., D'Ocon, P. and Ivorra, M. D. (2014) β-Adrenoceptors differentially regulate vascular tone and angiogenesis of rat aorta via ERK1/2 and p38. Vascular Pharmacology, 61(2-3), pp. 80-89. (doi: 10.1016/j.vph.2014.04.003) (PMID:24768830)

Full text not currently available from Enlighten.

Abstract

β-Adrenoceptors (β-ARs) modulate ERK1/2 and p38 in different cells, but little is known about the contribution of these signaling pathways to the function of β-ARs in vascular tissue. Immunoblotting analysis of rat aortic rings, primary endothelial (ECs) and smooth muscle cells (SMCs) isolated from aorta showed that β-AR stimulation with isoprenaline activated p38 in aortic rings and in both cultured cell types, whereas it had a dual effect on ERK1/2 phosphorylation, decreasing it in ECs while increasing it in SMCs. These effects were reversed by propranolol, which by itself increased p-ERK1/2 in ECs. Isoprenaline β-AR mediated vasodilation of aortic rings was potentiated by the ERK1/2 inhibitor, U0126, in the presence or absence of endothelium or L-NAME, whereas inhibition of p38 had no impact. Isoprenaline moderately decreased sprouting from aorta rings in the Matrigel angiogenesis assay; conversely propranolol not only prevented isoprenaline inhibition, but stimulated angiogenesis. ERK1/2 inhibition decreased angiogenesis, while a dramatic stimulation was observed by p38 blockade. Our results suggest that ERK1/2 activation after β-ARs stimulation in the smooth muscle hinders the vasodilator effect of isoprenaline, but in the endothelium β-ARs decreases ERK1/2 and increases p38 activity reducing therefore angiogenesis.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Carpena Garcia, Miss Nuria
Authors: Perez-Aso, M., Flacco, N., Carpena, N., Montesinos, M. C., D'Ocon, P., and Ivorra, M. D.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Vascular Pharmacology
Publisher:Elsevier
ISSN:15371891
ISSN (Online):1879-3649

University Staff: Request a correction | Enlighten Editors: Update this record